Evogene Ltd. (TLV:EVGN)
Israel · Delayed Price · Currency is ILS · Price in ILA 256.90
+7.00 (2.80%)
Apr 3, 2026, 1:44 PM IDT
Evogene Market Cap
Evogene has a market cap or net worth of 25.42 million as of April 2, 2026. Its market cap has decreased by -25.29% in one year.
Market Cap
25.42M
Enterprise Value
29.56M
Revenue
12.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
256.90
Market Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from 113.15M to 25.42M, a decrease of -77.54%. That is a compound annual growth rate of -7.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 3, 2026 | 25.42M | -2.99% |
| Dec 31, 2025 | 26.20M | -44.67% |
| Dec 31, 2024 | 47.35M | -68.75% |
| Dec 31, 2023 | 151.55M | 64.52% |
| Dec 29, 2022 | 92.12M | -58.37% |
| Dec 30, 2021 | 221.26M | -59.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 428.71M |
| Geffen Residence & Renewal | 268.22M |
| Matricelf | 98.70M |
| Clal Biotechnology Industries | 48.47M |
| BioLineRx | 33.94M |
| Can-Fite BioPharma | 20.57M |
| XTL Biopharmaceuticals | 19.87M |
| BioLight Life Sciences | 19.71M |